|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-7-1
|
|
pubmed:abstractText |
bcl-2 protein is detectable in human cancers and may be involved in the response to antineoplastic drugs or endocrine therapy in breast carcinomas. In a previous study, we had developed optimal technical conditions for bcl-2 immunodetection. The aim of the present report was to determine the prognostic significance of bcl-2 expression in breast carinomas by the use of a similar immunocytochemical procedure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2025-31
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9626199-Adult,
pubmed-meshheading:9626199-Aged,
pubmed-meshheading:9626199-Aged, 80 and over,
pubmed-meshheading:9626199-Breast Neoplasms,
pubmed-meshheading:9626199-Disease-Free Survival,
pubmed-meshheading:9626199-Follow-Up Studies,
pubmed-meshheading:9626199-Humans,
pubmed-meshheading:9626199-Image Processing, Computer-Assisted,
pubmed-meshheading:9626199-Immunohistochemistry,
pubmed-meshheading:9626199-Middle Aged,
pubmed-meshheading:9626199-Multivariate Analysis,
pubmed-meshheading:9626199-Prognosis,
pubmed-meshheading:9626199-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:9626199-Retrospective Studies
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up.
|
|
pubmed:affiliation |
Department of Pathology, Faculté de Médecine Timone, Institut Fédératif de Recherche en Cancérologie et Immunologie de Marseille, France. denis.charpin@wanadoo.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
